InMed Pharmaceuticals Inc., a pharmaceutical company focused on developing small molecule drug candidates for diseases with significant unmet medical needs, recently disclosed encouraging findings ...

INM-901 significantly reduced pro-inflammatory cytokines associated with Alzheimer'sStatistically significant reduction in ...

InMed Pharmaceuticals Inc. (NASDAQ: INM) shares improved greatly Tuesday, as the Vancouver-based pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates ...

A research team at Memorial Sloan Kettering Cancer Center (MSK) has made new insights into how the body forms immune cell ...

The Company initiated a trial run of its first direct-to-consumer advertising campaign on network TV in January ... This inflammatory condition affects the eyes and surrounding tissue and is often ...

The U.S. Food and Drug Administration (“FDA”), in partnership with the Department of Justice (“DOJ”), pursued significant and, in some ...

Large-capitalization blue-chip dividend stocks are a favorite among investors for a good reason. They provide a steady stream of passive income and offer a promising avenue for total return. Total ...

Green, a former pharmacist and pharma ad copywriter whose resume includes such agencies as Grey Healthcare and KPR (since ...

Trump’s pick to lead the Health Department is targeting a multibillion-dollar ad market that’s one of the biggest spenders on ...

"Partnering with GreenBe Pharma propels our mission to increase global accessibility to premium cannabis genetics,” said Jamie Blundell, CEO of Segra International. "This alliance underscores our ...

Next up, Tremfya made a triumphant return to the 2024 roundup after falling off the rankings in 2023. The med's return came ...

Skyrizi had an estimated national TV ad spend of $367.7 million — the highest ad spend of any brand in the top 10.